The following are ongoing Alzheimer’s Disease clinical trials in Canada:
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer’s Disease
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer’s Disease (AD)
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer’s Disease